Monitor Faecal Calprotectin Concentration in Infants With Heart Defects

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

May 1, 2018

Primary Completion Date

September 30, 2020

Study Completion Date

June 30, 2021

Conditions
CalprotectinCyanotic Heart Disease
Interventions
OTHER

feacal calprotectin concentration

"Intervention - To monitor the impact of cardiac surgery and enteral feeding on gut inflammation, biomarkers (faecal Calprotectin) will be measured 24-48hrs after surgery and 24-48hrs after enteral feed commences. Additionally, infants that are diagnosed with NEC will have calprotectin levels measured.~Faecal calprotectin - 50-100mg of faeces will be collected in plastic containers from infant's nappies. Samples will then be homogenised by shaking, and supernatants and then sent to laboratories for immediate analysis."

Trial Locations (1)

W1CN

Great Ormond Street Hospital, London

All Listed Sponsors
lead

Great Ormond Street Hospital for Children NHS Foundation Trust

OTHER

NCT03255564 - Monitor Faecal Calprotectin Concentration in Infants With Heart Defects | Biotech Hunter | Biotech Hunter